You just read:

Europe Approves JHL Biotech's Clinical Trial Application for Bevacizumab Biosimilar to Affordably Treat Colorectal, Lung, and Ovarian Cancers

News provided by

JHL Biotech, Inc.

22 Feb, 2018, 13:00 GMT